Home
China
World
Europe
Politics
Business
Opinions
Tech & Sci
Culture
Sports
Travel
Nature
Picture
Video
Live
TV
Specials
Learn Chinese
2024.11.05 21:14 GMT+8
GSK: AREXVY APPROVED IN CANADA FOR PREVENTION OF LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV IN ADULTS 50-59 YEARS OF AGE WHO ARE AT INCREASED RISK
Updated
2024.11.05 21:14 GMT+8
CGTN
Copyright ©
SHARE
RELATED STORIES
{{#contents.0.videos}}
{{/contents.0.videos}}
{{#contents.0.pictures}}
{{/contents.0.pictures}} {{^contents.0.pictures}}
{{/contents.0.pictures}}
{{contents.0.title}}